Tuesday, August 16, 2022
wellness India Expo
Home Tags Regulatory

Tag: Regulatory

Pricing pressures & regulatory scrutiny persist in US generics pharma industry:...

Some major Indian pharmaceutical companies reported sizeable impairment losses and also announced discontinuation of some products or segments due to lower earnings potential

Sanofi & GSK to seek USFDA & EMA approval for Covid-19...

When used as a two-dose primary series, the Sanofi-GSK vaccine delivered robust levels of neutralizing antibodies, with GMTs reaching 3711 units

Dedicated national R&D policy to bolster Indian pharma sector

Experts discuss regulatory reforms, ease of doing business during health and wellness week at India Pavilion

Mankind Pharma seeks CDSCO’s nod to conduct phase-1 clinical trials of...

A patented first in class novel anti-diabetic molecule, MKP10241 is a potent and orally administered small molecule, GPR119 agonist.........................

Govt fast-tracks regulatory approvals to fight COVID -19

In order to accelerate research and development pertaining to COVID-19, the Review Committee on Genetic Manipulation (RCGM) functioning in DBT has processed/considered more than 100 applications till date, on a fast-track mode....................

Cipla gets regulatory nod to launch Ciplenza for mild & moderate...

Cipla Limited has announced that it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.................

Sun Pharma seals US$ 145 million deal with SPARC over potential...

The two companies have announced a worldwide licensing agreement on the development and commercialization of SCD-044 which is being evaluated as a potential oral treatment for atopic dermatitis, psoriasis and other auto-immune disorders.............

DCGI approves Nintedanib for the treatment of systemic sclerosis-associated interstitial lung...

Being the first and only approved treatment option available for people living with SSc-ILD, the approval constitutes a breakthrough in an area of high unmet need. Following the FDA’s approval in September 2019, Nintedanib in SSc-ILD has so far been approved in 15 countries including the European Union, Canada, Japan and Brazil.................

Agilent improves bioanalytical workflow solutions

Updated system meets challenges of India’s changing lab landscape................

Experts deliberate on Medical Devices Bill with focus on global harmonization

NITI Aayog discusses the roadmap to create a robust regulatory regime with relevant industry stakeholders..................